Targetgene Biotechnologies
Company Details
Status: Private
Employees: 1-10
Location:
Rehovot, Israel
Type:
sample
Technology:
sample
sample
sample
sample
About: TargetGene is an innovative and agile biotechnology company in it’s development stage poised for expansion. TargetGene’s R&D is centered around creating efficient and supremely specific DNA editing solutions in living organisms. TargetGene, with it's patented and patent pending "T∙GEE" (Genome Editing Engine) platform is the first to invent RNA-guided gene-targeting. TargetGene is aiming to implement the "T∙GEE" platform for human gene-therapy with a focus on inherited diseases and cell-based immunotherapy.
TargetGene’s platforms include In-Vivo assembling nucleases targeted to the cell's genetic material. Highly specific Targeting is achieved through use of the principle of nucleic acid hybridization.
Keywords: Genome editing, Gene Targeting, Genome engineering, Nucleases, RNA-guided Genome Engineering (RGEN), Immunotherapy, Cell-based Therapy, Gene Thearapy, Immuno-oncology.
Our new laboratories are situated in the Rehovot Science park, Oppenheimer 10, Rehovot, Israel.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Targetgene Biotechnologies | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.